Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Iron Oxide Particles For Atheroma Imaging.

T. Tang, K. Muller, M. Graves, Z. Li, S. Walsh, V. Young, U. Sadat, S. Howarth, J. Gillard
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The selection of patients for vascular interventions has been solely based on luminal stenosis and symptomatology. However, histological data from both the coronary and carotid vasculature suggest that other plaque features such as inflammation may be more important in predicting future thromboembolic events. Ultrasmall superparamagnetic iron oxide (USPIO) contrast agents have been used for noninvasive MRI assessment of atherosclerotic plaque inflammation in humans. It has reached the stage of development to have been recently used in an interventional drug study to not only assess inflammatory progression but also select patients at high risk. This article reviews the basic science behind the use of USPIO contrast agents in atheroma MR imaging, experimental work in animals, and how this has led to the emergence of this promising targeted imaging platform for assessment of high risk carotid atherosclerosis in humans.
This paper references
10.1093/BRAIN/AWH191
In vivo MRI of brain inflammation in human ischaemic stroke.
A. Saleh (2004)
10.1016/J.ATHEROSCLEROSIS.2004.08.017
Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging.
Walter J Rogers (2005)
10.1161/01.CIR.0000068315.98705.CC
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging
M. E. Kooi (2003)
10.1002/mrm.10541
MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE
M. Rausch (2003)
In vivo mri of
A Saleh
10.1097/00004424-199510000-00006
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
E. Schulze (1995)
10.1161/01.STR.0000190895.51934.43
The Vulnerable Carotid Artery Plaque: Current Imaging Methods and New Perspectives
N. Nighoghossian (2005)
10.1161/STROKEAHA.108.521393
Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
D. Izquierdo-Garcia (2009)
Ex vivo MR imaging of atherosclerotic rabbit aorta labelled with USPIO - Enhancement of iron loaded regions in UTE imaging.
L. Crowe (2005)
10.1002/jmri.20930
MRI detection of macrophages labeled using micrometer‐sized iron oxide particles
J. B. Williams (2007)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.2176/NMC.48.157
Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque.
I. Kawahara (2008)
10.1161/01.ATV.0000194098.82677.57
Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration
F. Hyafil (2006)
10.1016/j.biomaterials.2008.05.015
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
10.1016/0076-6879(90)86093-B
Role of free radicals and catalytic metal ions in human disease: an overview.
B. Halliwell (1990)
10.1161/01.STR.0000131268.50418.b7
In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI
R. Trivedi (2004)
10.1093/BRAIN/AWH191
In vivo MRI of brain inflammation in human ischaemic stroke.
A. Saleh (2004)
10.1148/RADIOL.2283020322
Targeting of hematopoietic progenitor cells with MR contrast agents.
H. Daldrup-Link (2003)
10.1007/s00330-008-0965-2
MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients
E. Spüntrup (2008)
10.1002/mrm.10292
T1‐insensitive flow suppression using quadruple inversion‐recovery
V. Yarnykh (2002)
10.1038/nbt1159
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
R. Weissleder (2005)
10.1002/BJS.1800820117
Fate of the non‐operated carotid artery after contralateral endarterectomy
A. Naylor (1995)
10.1056/NEJM199906173402418
Atherosclerosis--an inflammatory disease.
Kenny J. Williams (1999)
The asymptomatic carotid surgery trial (ACST).
A. Halliday (1995)
10.1002/jmri.20649
Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide
C. Herborn (2006)
10.1002/mrm.10292
T1‐insensitive flow suppression using quadruple inversion‐recovery
V. Yarnykh (2002)
10.1148/RADIOL.2283020322
Targeting of hematopoietic progenitor cells with MR contrast agents.
H. Daldrup-Link (2003)
10.1002/jmri.20930
MRI detection of macrophages labeled using micrometer‐sized iron oxide particles
J. B. Williams (2007)
10.1002/mrm.10417
Imaging single mammalian cells with a 1.5 T clinical MRI scanner
Paula Foster-Gareau (2003)
10.1002/mrm.10417
Imaging single mammalian cells with a 1.5 T clinical MRI scanner
Paula Foster-Gareau (2003)
10.1097/01.rli.0000101027.57021.28
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
10.1007/s00330-008-0965-2
MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients
E. Spüntrup (2008)
10.1161/01.STR.0000236063.47539.99
Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI
T. Tang (2006)
10.1097/01.rli.0000101027.57021.28
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
10.1227/01.NEU.0000239895.00373.E4
Histopathology of Carotid Atherosclerotic Disease
R. Virmani (2006)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
10.1016/j.biomaterials.2008.03.006
Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
K. Mueller (2008)
10.1002/mrm.10541
MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE
M. Rausch (2003)
10.1212/01.WNL.0000132962.12841.1D
Noninvasive imaging of carotid plaque inflammation
R. Trivedi (2004)
10.1016/S0002-8703(99)70266-8
Atherosclerosis--an inflammatory disease.
R. Ross (1999)
10.1016/j.biomaterials.2008.05.015
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
10.1016/j.ejrad.2008.01.047
Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals.
S. Howarth (2009)
10.1161/01.STR.0000236063.47539.99
Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI
T. Tang (2006)
10.1016/0304-4165(86)90020-6
Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro.
M. Pratten (1986)
10.1007/s00330-007-0712-0
MR angiography with blood pool contrast agents
J. Bremerich (2007)
10.1161/STROKEAHA.108.521393
Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
D. Izquierdo-Garcia (2009)
10.1097/01.TP.0000089237.39220.83
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques
A. Arbab (2003)
10.1161/01.CIR.103.3.415
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
The asymptomatic carotid surgery trial (ACST).
A. Halliday (1995)
10.1016/0304-4165(86)90020-6
Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro.
M. Pratten (1986)
10.1093/AJCN/83.2.456S
Inflammation and cardiovascular disease mechanisms.
P. Libby (2006)
10.1002/mrm.10532
Improved molecular imaging contrast agent for detection of human thrombus
P. Winter (2003)
Online ISSN
Umar Sadat
Ex vivo MR imaging of atherosclerotic rabbit aorta labelled with USPIO - Enhancement of iron loaded regions in UTE imaging.
L. Crowe (2005)
10.1002/jmri.20649
Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide
C. Herborn (2006)
10.1002/jmri.20283
Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling
A. D. Yancy (2005)
10.1161/01.CIR.103.3.415
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
Ferumoxtran-10 Advanced Magnetics.
W. Leenders (2003)
Histopathology of carotid atherosclerotic disease. Neurosurgery. 2006;59:S219–S227; discussion S213–S213
R Virmani (2006)
10.1161/01.ATV.0000222920.59760.df
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages
R. Trivedi (2006)
10.1038/nbt1159
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
R. Weissleder (2005)
10.1161/01.STR.0000131268.50418.b7
In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI
R. Trivedi (2004)
10.1021/AC701976P
Multiparameter magnetic relaxation switch assays.
S. Taktak (2007)
10.1016/0076-6879(90)86093-B
Role of free radicals and catalytic metal ions in human disease: an overview.
B. Halliwell (1990)
10.1016/j.ejrad.2008.01.047
Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals.
S. Howarth (2009)
10.1007/s00330-007-0712-0
MR angiography with blood pool contrast agents
J. Bremerich (2007)
10.1161/01.CIR.0000068315.98705.CC
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging
M. E. Kooi (2003)
10.2176/NMC.48.157
Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque.
I. Kawahara (2008)
10.1093/AJCN/83.2.456S
Inflammation and cardiovascular disease mechanisms.
P. Libby (2006)
10.1161/01.ATV.0000194098.82677.57
Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration
F. Hyafil (2006)
10.1002/BJS.1800820117
Fate of the non‐operated carotid artery after contralateral endarterectomy
A. Naylor (1995)
7272 Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA
Greenville Avenue (2009)
10.1136/jnnp.2007.118901
Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study
T. Tang (2007)
10.1161/01.STR.0000190895.51934.43
The Vulnerable Carotid Artery Plaque: Current Imaging Methods and New Perspectives
N. Nighoghossian (2005)
10.1227/01.NEU.0000239895.00373.E4
Histopathology of Carotid Atherosclerotic Disease
R. Virmani (2006)
10.1002/jmri.1194
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles
S. A. Schmitz (2001)
10.1016/j.ejvs.2007.10.019
Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study.
T. Tang (2008)
Accumu - lation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging
ME Kooi (2003)
inflammation in human ischaemic stroke
D Izquierdo-Garcia (2004)
10.1016/s0074-6142(00)80096-0
[Methods and techniques].
J. Hamers (1997)
10.1016/J.ATHEROSCLEROSIS.2006.08.048
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques.
C. von zur Muhlen (2007)
10.1016/J.BIOMATERIALS.2006.12.003
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
10.1136/jnnp.2007.118901
Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study
T. Tang (2007)
10.1212/01.WNL.0000132962.12841.1D
Noninvasive imaging of carotid plaque inflammation
R. Trivedi (2004)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1016/0730-725X(93)90470-X
Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
C. Chambon (1993)
10.1097/01.TP.0000089237.39220.83
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques
A. Arbab (2003)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1148/RG.243035190
MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
M. Harisinghani (2004)
Ferumoxtran-10 Advanced Magnetics.
W. Leenders (2003)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)



This paper is referenced by
Assessment of carotid plaque inflammation in diabetic and non-diabetic patients-an exploratory USPIO-enhanced MR imaging study
A. Usman ()
10.1007/s12195-017-0504-9
Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging
M. Ahmed (2017)
10.1002/jmri.25459
RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm
Toshiro Kitagawa (2017)
10.1007/8415_2011_95
Patient-Specific Analysis of Blood Flow and Mass Transport in Small and Large Arteries
X. Y. Xu (2011)
Cell response to imaging contrast agents suggested for atherosclerotic plaque imaging
Amit Laskar (2013)
10.3233/JCB-15020
Strategies to enhance nanoparticle-endothelial interactions under flow
I. Cicha (2016)
10.1002/cmmi.1598
Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes
B. Gustafsson (2015)
10.1016/j.cis.2013.06.007
Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
T. Lam (2013)
10.1007/s00775-013-1054-9
Multimodality PET/MRI agents targeted to activated macrophages
C. Tu (2013)
10.1007/978-1-4614-7425-8_4
Quantitative MR Analysis for the Assessment of Carotid Atherosclerosis
A. Schindler (2014)
10.1016/j.ejvs.2015.12.018
Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms
O. McBride (2016)
10.2147/IJN.S127349
Current applications and future prospects of nanomaterials in tumor therapy
Yu Huang (2017)
10.1016/j.mri.2017.08.006
The development and optimisation of 3D black-blood R2* mapping of the carotid artery wall.
J. Yuan (2017)
Novel molecular imaging of cardiovascular disease in man
N. Joshi (2016)
10.1016/j.jstrokecerebrovasdis.2016.10.034
Assessment of Carotid Plaque Inflammation in Diabetic and Nondiabetic Patients-An Exploratory Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging Study.
A. Usman (2017)
10.1007/s00204-010-0577-x
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
D. Kell (2010)
10.1002/mabi.201400029
Magnetic nanoclusters engineered by polymer-controlled self-assembly for the accurate diagnosis of atherosclerotic plaques via magnetic resonance imaging.
Myeong-Hoon Kim (2014)
10.1007/978-3-642-12945-2_31
Imaging in Cardiovascular Research
M. Schaefers (2011)
Magnetic resonance imaging of engineered tissues: enhanced contrast and ultrashort echo time MRI
Yi Sun (2014)
10.1007/S12410-010-9028-6
Emerging Molecular Targets for Intravascular Imaging of High-Risk Plaques
J. Kim (2010)
10.1016/J.JMMM.2020.167428
Cardiovascular applications of magnetic particles
I. Cicha (2020)
10.1161/ATVBAHA.112.300707
Scavenger Receptor-AI–Targeted Iron Oxide Nanoparticles for In Vivo MRI Detection of Atherosclerotic Lesions
F. M. E. Segers (2013)
10.1586/erc.11.168
Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis
A. Degnan (2012)
10.1007/978-1-4939-3121-7
Nanomaterials in Pharmacology
Z. Lu (2016)
10.1039/C5TB01014D
Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.
M. Bruckman (2015)
10.1007/s12350-014-9959-4
Molecular imaging of plaque vulnerability
S. Tavakoli (2014)
10.1097/RLI.0b013e3182631e68
Anti-Inflammatory Drug Evaluation in ApoE−/− Mice by Ultrasmall Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
M. Sigovan (2012)
10.1515/ntrev-2012-0080
Functionalized nanomaterials: their use as contrast agents in bioimaging: mono- and multimodal approaches
Quentin Le Tréquesser (2013)
10.1016/j.ejvs.2010.08.022
Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms--a feasibility study.
U. Sadat (2011)
10.1515/ejnm-2014-0001
Cardiovascular therapy through nanotechnology – how far are we still from bedside?
I. Cicha (2014)
10.1016/j.bbagen.2013.01.021
Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid.
L. Liu (2013)
10.1016/j.atherosclerosis.2013.03.019
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
A. Millon (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar